Hakima
Hakima Abou-Rachid, Quebec CA
Patent application number | Description | Published |
---|---|---|
20140199546 | MULTI-BRANCHED N-DOPED CARBON NANOTUBES AND THE PROCESS FOR MAKING SAME - A multibranched N-doped carbon nanotube (CNT) and the process of production are described. The CNT includes a first-stage stalk having a direction comprising a first-stage base, and a first-stage top opposite to and attached with the first-stage base, at least two second-stage bundles, each of which comprises a second-stage base attached to the first-stage top, and second-stage top opposite to and attached with the second-stage base, and wherein the second-stage bundles branch from the first-stage stalk in substantially the direction of the first stage stalk, and a plurality of third-stage nanotubes each of which comprises a third-stage base attached to the second-stage top, a third-stage top opposite to and attached with the third-stage base, and wherein the plurality of third-stage nanotubes branch from the second-stage bundles. | 07-17-2014 |
Hakima Amri, Bethesda, MD US
Patent application number | Description | Published |
---|---|---|
20150031069 | Phylogenetic Analysis of Mass Spectrometry or Gene Array Data for the Diagnosis of Physiological Conditions - A universal data-mining platform capable of analyzing mass spectrometry (MS) serum proteomic profiles and/or gene array data to produce biologically meaningful classification; i.e., group together biologically related specimens into clades. This platform utilizes the principles of phylogenetics, such as parsimony, to reveal susceptibility to cancer development (or other physiological or pathophysiological conditions), diagnosis and typing of cancer, identifying stages of cancer, as well as post-treatment evaluation. To place specimens into their corresponding clade(s), the invention utilizes two algorithms: a new data-mining parsing algorithm, and a publicly available phylogenetic algorithm (MIX). By outgroup comparison (i.e., using a normal set as the standard reference), the parsing algorithm identifies under and/or overexpressed gene values or in the case of sera, (i) novel or (ii) vanished MS peaks, and peaks signifying (iii) up or (iv) down regulated proteins, and scores the variations as either derived (do not exit in the outgroup set) or ancestral (exist in the outgroup set); the derived is given a score of “1”, and the ancestral a score of “0”—these are called the polarized values. Furthermore, the shared derived characters that it identifies are potential biomarkers for cancers and other conditions and their subclasses. | 01-29-2015 |
Hakima Belbachir, Grenoble FR
Patent application number | Description | Published |
---|---|---|
20130338224 | DECONTAMINATING COMPOSITION HAVING SIMULTANEOUSLY BACTERICIDAL, FUNGICIDAL AND VIROCIDAL PROPERTIES, METHODS FOR OBTAINING AND USING SAID COMPOSITION - The invention concerns a decontaminating composition having simultaneously bactericidal, fungicidal and virocidal properties, comprising as active components eugenol, eugenol acetate, vanillin and carvacrol, characterized in that said active constituents are present in the following percentages by weight: at least about 12% eugenol, at least about 3% eugenol acetate, at least about 0.1% vanillin and at least about 0.5% carvacrol. Said decontaminating composition can be used as liquid or solid soaps. It can also impregnate in liquid form fabrics and nonwoven fabrics such as garments for medical use, bed sheets, slip covers, surgery drape, dressings and gauze such as those applied to the skin of serious burn victims. | 12-19-2013 |
Hakima Sbai, Providence, RI US
Patent application number | Description | Published |
---|---|---|
20140316122 | HEPATITIS B VIRUS VACCINES - This document provides methods and materials for producing immune responses against hepatitis B viruses. For example, polypeptides, nucleic acid molecules encoding such polypeptides, virus-like particles containing such polypeptides, vaccine preparations containing one or more polypeptides provided herein, vaccine preparations containing one or more nucleic acid molecules provided herein, vaccine preparations containing one or more virus-like particles provided herein, and methods for inducing immune responses against hepatitis B viruses within mammals (e.g., humans) are provided. | 10-23-2014 |